[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100233303":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":28,"responsibleParty":46,"collaborators":10,"id":48,"slug":10,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":10,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"intestinal transplantation",null,"all performed intestinal transplants underwent the same Leuven intestinal transplant protocol",[13],"Procedure: intestinal transplantation",[15],{"type":16,"name":9,"description":10,"armGroupLabels":17,"otherNames":10},"PROCEDURE",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Jacques Pirenne, MD,PhD,MsC","CONTACT","+32 16 34 87 27","jacques.pirenne@uzleuven.be",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Laurens J Ceulemans, MD","+32 16 34 15 45","laurens.ceulemans@uzleuven.be",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"UZ Leuven","RECRUITING","Leuven","3000","Belgium",{"type":36,"coordinates":37},"Point",[38,39],4.70093,50.87959,{"lat":39,"lon":38},[42],{"name":43,"role":21,"phone":44,"phoneExt":10,"email":45},"Sarah Mertens","+32 16 34 29 61","sarah.mertens@uzleuven.be",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100233303",false,"NCT02314949","Leuven Tolerogenic Protocol for Intestinal Transplantation","A Multifactorial Immunomodulatory Protocol -Promoting T-regulatory Cells- Prolongs Graft and Patient Survival After Intestinal Transplantation","LP","Inclusion Criteria:\n\n* all patients awaiting intestinal transplantation\n\nExclusion Criteria:\n\n* living donation","ALL",{"count":57,"type":58},13,"ESTIMATED","OBSERVATIONAL","An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells.\n\nThis protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.",[62,63],"Organ Transplantation","Intestine",[65,66,67],"T-regulatory cells","Tolerogenic protocol","immunomodulation","2024-07-12",{"date":70,"type":71},"2024-07-15","ACTUAL",{"date":73,"type":10},"2000-10",{"date":75,"type":58},"2025-01",{"name":5,"class":6},1]